Home » Probe of GSK’s China Operations Targeting Chinese Executives
Probe of GSK’s China Operations Targeting Chinese Executives
November 11, 2013
Chinese authorities reportedly are preparing to prosecute individual GlaxoSmithKline officials in China for bribery, rather than bring charges against GSK’s entire China division, according to sources with knowledge of the ongoing investigation.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor